QHS
Cleveland Clinic
 
 
 
Research Activities

Hemodialysis Study (HEMO)

The HEMO (Hemodialysis) Study was a multi-center randomized clinical trial supported by NIDDK. The Department served as the Data Coordinating Center. The aims of the study were to evaluate in a 2x2 factorial design the effect of dose of dialysis and dialyzer membrane flux on the mortality and morbidity in chronic hemodialysis patients.

The HEMO Study clinical trial ended patient follow-up on December 31, 2001. There were 1846 patients enrolled in this trial who were followed up to 6.5 years. The design and primary results of the trial are :

Go Back
Printer Friendly Page
Notice of Privacy Practices
 
News
 
Michael Kattan, PhD, Chair of Quantitative Health Sciences, recently received the Eugene Saenger Distinguished Service Award from the Society for Medical Decision Making and was named as a permanent member to the NIH Epidemiology of Cancer Study Section. Dr. Kattan also will be editing the forthcoming Encyclopedia of Medical Decision Making.

Measuring the Accuracy of Prediction Models
An International Symposium

September 29, 2008
Cleveland Clinic

Sponsored by:
Cleveland Clinic Department of Quantitative Health Sciences
With generous support from the Page Foundation
 
 
   
  Home | Research Activities and Software | Contact Information | Department Members | Career Opportunities |
| Links Of Interest | Cleveland Chapter of the American Statistical Association | Department Information For Internal Use Only |
© Department of Quantitative Health Sciences 2005